Am J Transplant, Volume 20, Suppl 3 Archives - Page 198 of 223 - ATC Abstracts

2020 American Transplant Congress
Safety of Belatacept in HIV-Positive Kidney Transplant Recipients
K. El Sakhawi¹, A. Scemla², D. Bertrand³, C. Garrouste⁴, P. Malvezzi⁵, P. Grimbert¹, M. Matignon¹
¹Nephrology, APHP Henri Mondor, Créteil, France, ²Nephrology, APHP Necker Enfants Malades, Paris, France, ³Nephrology, CHU Bois Guillaume, Rouen, France, ⁴Nephrology, CHU Clermond Ferrand, Clermont Ferrand, France, ⁵Nephrology, CHU Grenoble, Grenoble, France
*Purpose: Kidney allograft survival in HIV-infected patients is lower than in the general population. Belatacept (instead of anticalcineurins (CNI)) has been shown to have a…
2020 American Transplant Congress
Liver Transplantation of Donors and Recipients’ with Situs Inversus Totalis: Case Reports and Literature Review
L. Del Angel Diaz, A. Simioni, G. D'Amico, Q. Liu, K. Hashimoto, M. Fujiki, B. Eghtesad, F. Aucejo, K. Sasaki, C. Kwon, C. Miller, C. Quintini, T. Diago-Uso
Cleveland Clinic, Cleveland, OH
*Purpose: Situs Inversus Totalis (SIT) is a rare condition affecting 0.1% of the general population. It was historically a contraindication for LTx and graft donation.…
2020 American Transplant Congress
Pre-Transplant Overt Hepatic Encephalopathy is Associated with Greater Cognitive Improvement after Liver Transplant
M. Kim¹, J. Menzel-Smith¹, J. D. Peipert², K. J. Reid¹, P. Zee¹, D. P. Ladner³
¹Neurology, Northwestern University, Chicago, IL, ²Northwestern University, Chicago, IL, ³Surgery, Northwestern University, Chicago, IL
*Purpose: Persistent or residual cognitive impairment following liver transplant is frequently reported yet not well-characterized.*Methods: Cognitive function was tested in a prospective cohort of patients…
2020 American Transplant Congress
Evaluation of Tacrolimus Dose Requirement in Liver Transplant Recipients from African American Donors Compared to Non-African American Donors
K. Guilbert, I. Plasari, S. Wiehe, F. Gordon
Lahey Hospital and Medical Center, Burlington, MA
*Purpose: The purpose of this study is to evaluate whether a difference in tacrolimus total daily dose (TDD) exists between those receiving a liver transplant…
2020 American Transplant Congress
Beyond Milan- Not Paying the Price
A. Mathur, C. Brennan, D. Tsapepas, M. Najjar, O. Perez, A. Griesemer, T. Kato, J. Emond
Columbia University, New york, NY
*Purpose: Early stage hepatocellular carcinoma (HCC) patients meeting the Milan Criteria have access to Orthotopic Liver Transplantation (OLT) as a curative treatment. However, a substantial…
2020 American Transplant Congress
Myosteatosis and its Impact on Graft- and Patient Survival in Adult Recipients of Deceased Donor Liver Transplantation
Z. Czigany, W. Kramp, G. van der Kroft, P. Strnad, M. Zimmermann, W. Liu, G. Wiltberger, U. Neumann, G. Lurje
University Hospital RWTH Aachen, Aachen, Germany
*Purpose: Recently our group demonstrated the role of myosteatosis in inferior perioperative outcomes (Czigany et al. Am J Transplant 2019) in recipients of orthotopic liver…
2020 American Transplant Congress
Early versus Delayed Initiation of CMV Prophylaxis after Liver Transplantation
M. Magid, J. Byrns, J. Gommer, Z. Yang, M. Harris
Duke University Hospital, Durham, NC
*Purpose: To determine the incidence of CMV DNAemia in early (prior to post-op day 7) versus delayed prophylaxis in liver transplant recipients.*Methods: Retrospective, single-center study…
2020 American Transplant Congress
Efficacy and Safety According to Dose of Valganciclovir for Cytomegalovirus Prophylaxis in Transplantation Network Meta Analysis
S. Hwang, W. Park, K. Kim, J. Song, S. Lee
Inha University, Incheon, Korea, Republic of
*Purpose: Valgancivlovir is importantly used to prevent post-transplant CMV infection among kidney transplantation patients. However, the dose of such drug being used still remains controversial…
2020 American Transplant Congress
Development of Self-Limited Low-Level BK Viremia/Viruria Suggests Ideal Immunosuppression to Suppress T-Cell and Antibody-Mediated Rejection and to Preserve Kidney Allograft Function
B. Näf, T. Müller, R. Wüthrich, T. Schachtner
University Hospital Zurich, Zurich, Switzerland
*Purpose: Polyomavirus BK (BKV) has been suggested as a surrogate marker of overimmunosuppression. Due to recent advances in monitoring strategies and pre-emptive therapy, progression to…
2020 American Transplant Congress
A Call to Action: Finding the Right Kidney for All Potential Recipients
G. Guerra, L. Preczewski, A. Harshman, G. Ciancio, R. Vianna, J. Figueiro, M. Muldoon
Miami Transplant Institute, Miami, FL
*Purpose: The dialysis burden in patients with end stage renal disease (ESRD) awaiting a kidney transplant (KT) is a huge driver of morbidity, mortality, and…